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H I G H L I G H T S
• Alcohol use and alcohol use disorder (AUD) prevalence rates varied across countries.• Mean lifetime prevalences were 80% for alcohol use and 8.6% for AUD.• Risk of AUD onset began in adolescence, with 15% of all cases developed by age 18.• Comorbidity was high, with other mental disorders most often preceding AUD onset.• Patterns of AUDs and correlates were consistent across counties.








A B S T R A C T
Background: Prevalences of Alcohol Use Disorders (AUDs) and Mental Health Disorders (MHDs) in many in-
dividual countries have been reported but there are few cross-national studies. The WHO World Mental Health
(WMH) Survey Initiative standardizes methodological factors facilitating comparison of the prevalences and
associated factors of AUDs in a large number of countries to identify differences and commonalities.
Methods: Lifetime and 12-month prevalence estimates of DSM-IV AUDs, MHDs, and associations were assessed
in the 29 WMH surveys using the WHO CIDI 3.0.
Results: Prevalence estimates of alcohol use and AUD across countries and WHO regions varied widely. Mean
lifetime prevalence of alcohol use in all countries combined was 80%, ranging from 3.8% to 97.1%. Combined
average population lifetime and 12-month prevalence of AUDs were 8.6% and 2.2% respectively and 10.7% and
4.4% among non-abstainers. Of individuals with a lifetime AUD, 43.9% had at least one lifetime MHD and 17.9%
of respondents with a lifetime MHD had a lifetime AUD. For most comorbidity combinations, the MHD preceded
the onset of the AUD. AUD prevalence was much higher for men than women. 15% of all lifetime AUD cases
developed before age 18. Higher household income and being older at time of interview, married, and more
educated, were associated with a lower risk for lifetime AUD and AUD persistence.
Conclusions: Prevalence of alcohol use and AUD is high overall, with large variation worldwide. The WMH
surveys corroborate the wide geographic consistency of a number of well-documented clinical and epidemio-
logical findings and patterns.
1. Introduction
Alcohol Use Disorders (AUDs) are serious psychiatric conditions
often leading to major adverse consequences. The 2018 World Health
Organization's (WHO) Global Status Report on Alcohol and Health de-
termined that in 2016 harmful use of alcohol caused approximately 3
million deaths (or 5.3% of all deaths), more than hypertension and
diabetes combined. The WHO report estimated that 5.1% of the global
burden of disease and injury, equivalent to 132.6 million Disability-
adjusted Life Years (DALYs), was caused by alcohol use(World Health
Organization, 2018). In 2016, an estimated 2.3 billion people were
current drinkers and 283 million people aged 15+ years had an AUD
(5.1% of adults). The economic burden of alcohol use has been esti-
mated to be more than 1% of the gross national product in middle and
high income countries(Rehm, Mathers, Popova, et al., 2009). Alcohol
use was the 7th leading risk for early death and disability(GBD 2016
Alcohol Collaborators, 2018). Despite some decrease in per capita al-
cohol use in some WHO regions, worldwide per capita alcohol con-
sumption is predicted to increase over the next 10 years with a possible
increase in disease burden(World Health Organization, 2018). Multi-
country epidemiologic data on AUDs can enable better understanding
of patterns and characteristics of AUDs providing necessary information
for prevention and treatment implementation and policy. There is little
cross-national standardized data available(Baxter, Patton, Scott, et al.,
2013; Steel, Marnane, Iranpour, et al., 2014). It is difficult to compare
findings from different studies as they generally have not used
equivalent assessments, administrations, diagnostic systems, sampling
and analysis approaches. A few limited multi-country or regional stu-
dies using a standardized assessment have been conducted. One early
notable effort used the Diagnostic Interview Schedule(Robins, Helzer,
Croughan, et al., 1981) which includes an assessment of DSM-III
(American Psychiatric Association, 1980) alcohol abuse and
dependence to assess samples in coordinated studies in 10 different
cultural regions(Helzer & Canino, 1992). There was wide variation in
the lifetime prevalence rates of DSM-III alcohol abuse and/or depen-
dence ranging from 0.45% in Shanghai to 22% in Korea and 23% in
United States native Mexican Americans although there was similarity
in a number of associated variables.
The WHO World Mental Health (WMH) Survey Initiative(Kessler &
Üstün, 2004) standardizes survey design and implementation proce-
dures that facilitate the comparison of estimates of prevalence and
correlates of AUDs in a large number of participating countries(Kessler,
Abelson, Demler, et al., 2004; Kessler, Heeringa, Pennell, et al., 2018;
Kessler & Üstün, 2004), making the study especially useful for in-
vestigating cross-national characteristics of disorders(Glantz, Medina-
Mora, Petukhova, et al., 2014). This paper reports findings on the
prevalences and correlates of AUDs in the WMH countries.
2. Methods
Data for this paper come from 29 WMH surveys carried out in 27
countries or country regions between 2001 and 2015. The list of par-
ticipating countries, their World Bank income classification(World
Bank, 2012), and the sample characteristics for each country including
the sample sizes are shown in Table 1.
Mental and substance use disorders were assessed using the WHO
Composite International Diagnostic Interview (CIDI) Version 3.0, a vali-
dated fully-structured lay-administered interview(Haro, Arbabzadeh-
Bouchez, Brugha, et al., 2006) generating lifetime and 12-month prevalence
estimates of DSM-IV-TR(American Psychiatric Association, 2000) mood,
anxiety, behavioral, and substance use disorders(Kessler & Üstün, 2004).
The CIDI assesses AUDs by asking a series of questions that operationalize
the DSM-IV symptom criteria for Alcohol Abuse (ALA) and Alcohol De-
pendence (ALD). Respondents who met criteria for either ALA or ALD were
M.D. Glantz, et al. Addictive Behaviors 102 (2020) 106128
2
considered to have an AUD. Consistent with DSM-IV, any respondents who
met criteria for both AUD disorders were diagnosed with ALD.
In an effort to reduce respondent burden a two-part sampling design
was used in which all respondents were administered a Part I interview
that contained questions about disorders of primary interest to the
WMH investigators. A Part II sample, consisting of 100% of the Part I
respondents who met lifetime criteria for any of the disorders assessed
in Part I plus a probability sample (typically in the range between 20%
and 33% depending on the country) of other Part I respondents were
administered Part II of the survey. The Part II sample included questions
about disorders of secondary interest along with questions about risk
factors and consequences of disorders. The non-certainty respondents in
the Part II sample were weighted by the inverse of their probability of
selection so that weighted prevalence estimates of Part I disorders in the
Part II sample are identical to unweighted estimates of these disorders
in the Part I sample. Weights were also used to match the samples to
population socio-demographic distributions. As discussed in detail
elsewhere,(Heeringa, Wells, Hubbard, et al., 2008) the sequence of
steps in calculating analysis weights was the same across WMH surveys
but differed in exact procedures depending on the sample frame and
access to population data for post-survey adjustments. A total of
123,237 respondents across the 29 surveys were assessed for AUDs. The
Part II sample includes 79,343 respondents. Further details on the
WMH surveys are summarized in the Appendix Methods.
3. Data analysis
All analyses were based on weighted data, accounting for stratifi-
cation and clustering. Standard errors were estimated using Taylor
series linearization as implemented in Statistical Analysis System®
(SAS) Version 9.4(SAS Institute Inc, 2019). SAS PROC LIFETEST was
used to produce life-table estimates of the age-of-onset (AOO) dis-
tributions of AUD and are reported as weighted prevalences. The as-
sociations of sociodemographic variables (see Appendix Methods for
full list) with lifetime AUD prevalence as of given ages were assessed
using discrete-time logistic regression analyses with person-year the
unit of analysis. Similar analyses using standard logistic regression were
used to investigate correlates of past year AUD among non-abstainers
defined as those who report at least some use of alcohol in their life-
times. Results are presented as odds ratios (OR) and 95% confidence
intervals (CI). Tests of significance were evaluated using Wald F tests
based on design-corrected coefficient variance-covariance matrices
with statistical significance defined at the 2-tailed 0.05 level.
Table 1
WMH sample characteristics by World Bank income categories.a
Country Sampling Field dates Age rangeb Sample size Response ratec
Part 1 Part 2
Low and lower-middle income countries
Colombia All urban areas of the country (about 73% of the total national population) 2003 18–65 4426 2381 87.7%
Iraq Nationally representative 2006–7 18–96 4332 4332 95.2%
Nigeria 21 of the 36 states in the country (about 57% of the national population) 2002–4 18–100 6752 2143 79.3%
China Beijing and Shanghai metropolitan areas 2001–3 18–70 5201 1628 74.7%
Peru All urban areas of the country 2004–5 18–65 3930 1801 90.2%
Ukraine Nationally representative 2002 18–91 4725 1720 78.3%
Total 29,366 14,005 82.8%
Upper-middle income countries
Brazil São Paulo metropolitan area 2005–8 18–93 5037 2942 81.3%
Bulgaria Nationally representative 2002–6 18–98 5318 2233 72.0%
Colombia Medellin metropolitan area 2011–12 19–65 3261 1673 97.2%
Lebanon Nationally representative 2002–3 18–94 2857 1031 70.0%
Mexico All urban areas of the country (about 75% of the total national population) 2001–2 18–65 5782 2362 76.6%
Romania Nationally representative 2005–6 18–96 2357 2357 70.9%
South Africa Nationally representative 2002–4 18–92 4315 4315 87.1%
High income countries
Argentina Nationally representative 2015 18–98 3927 2116 77.3%
Australia Nationally representative 2007 18–85 8463 8463 60.0%
Belgium Nationally representative 2001–2 18–95 2419 1043 50.6%
France Nationally representative 2001–2 18–97 2894 1436 45.9%
Germany Nationally representative 2002–3 19–95 3555 1323 57.8%
Israel Nationally representative 2003–4 21–98 4859 4859 72.6%
Italy Nationally representative 2001–2 18–100 4712 1779 71.3%
Japan Eleven metropolitan areas 2002–6 20–98 4129 1682 55.1%
The Netherlands Nationally representative 2002–3 18–95 2372 1094 56.4%
New Zealand Nationally representative 2004–5 18–98 12,790 7312 73.3%
North Ireland Nationally representative 2005–8 18–97 4340 1986 68.4%
Poland Nationally representative 2010–11 18–65 10,081 4000 50.4%
Portugal Nationally representative 2008–9 18–81 3849 2060 57.3%
Spain Nationally representative 2001–2 18–98 5473 2121 78.6%
Spain Murcia region 2010–12 18–96 2621 1459 67.4%
United States Nationally representative 2001–3 18–99 9282 5692 70.9%
Total 85,766 48,425 63.1%
Overall sample 144,059 79,343 69.2%
a The World Bank (2018) Data. Accessed August 2018 at: http://data.worldbank.org/country. Some of the WMH countries have moved into new income cate-
gories since the surveys were conducted. The income groupings above reflect the status of each country at the time of data collection. The current income category of
each country is available at the preceding URL.
b For the purposes of cross-national comparisons we limit the sample to those 18+.
c The response rate is calculated as the ratio of the number of households in which an interview was completed to the number of households originally sampled,
excluding from the denominator households known not to be eligible either because of being vacant at the time of initial contact or because the residents were unable
to speak the designated languages of the survey.

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2 shows the lifetime prevalence of alcohol use, ALA, ALD and
AUDs for each of the surveys, the countries combined, the countries
grouped by World Bank income levels, and the WHO regions. There are
significant differences in base rate prevalences of lifetime alcohol use
and all DSM-IV diagnoses across countries, income levels and regions,
as well as significant differences in prevalences when considered only
among non-abstainers.
The mean lifetime prevalence of alcohol use in all countries com-
bined was 80%, ranging from 3.8% in Iraq to 97.1% in Peru. The
average lifetime prevalence of ALA for all countries was 6.3%, ranging
from 0.5% in Iraq to 18.7% in Australia. The average lifetime pre-
valence of ALD for all countries was 2.3%, ranging from 0.2% in Iraq to
6.0% in the United States. As expected, the lifetime prevalence of ALD
was lower than ALA cross-nationally and for all within-country com-
parisons. The lifetime prevalence of AUDs for all countries combined
was 8.6% and ranged from 0.7% in Iraq to 22.7% in Australia.
The lifetime prevalence of AUDs among non-abstainers for all
countries combined was 10.7%. Once conditioned upon lifetime alcohol
use, there was a noticeable shift in the ordering of prevalence across
surveys. When excluding lifetime alcohol abstainers, the highest pre-
valence of lifetime AUD was found in South Africa (28.3%) exceeding
that of Australia (24.1%) which had the highest unconditioned AUD
prevalence. The lowest conditional prevalences were found for Italy
with estimates of 1.2% for ALA, 0.5% for ALD, and 1.7% for AUD.
When all survey participants were considered, Iraq had the lowest
prevalence of AUDs. However, once conditioning on lifetime use, Iraq
fell in the top three of all surveys for AUD prevalence indicating a low
level of overall use but a high risk of AUD among users.
Unconditional lifetime prevalence of AUDs shows a clear positive
trend with country income level, increasing from 5.9% for AUDs in
low/lower-middle income countries to 7.2% in upper-middle income
countries and 10.3% in high-income countries. Comparisons of AUD
diagnoses by income group remain significant when conditioning upon
lifetime use of alcohol but the trend was less consistent. Comparing
between WHO regions, prevalence rates of AUDs were lowest among
the Eastern Mediterranean surveys and highest among the Western
Pacific surveys, regardless of whether conditioning on alcohol use or
not.
4.2. Past-year prevalence
Table 3 shows the prevalences of past-year alcohol use, ALA, ALD
and AUDs for all countries, income levels and WHO regions, as well as
past-year diagnoses conditional on past-year use. There were significant
differences in unconditional and conditional past-year alcohol use and
diagnoses across countries. The average 12-month prevalence of al-
cohol use was 52.3%, ranging from 1.7% in Iraq to 76.9% in Australia.
The average 12-month prevalence of ALA for all countries was 1.3%
and ranges from 0.1% in Iraq and Japan to 3.7% in the Ukraine. Similar
to observations among lifetime prevalences, within-survey comparisons
show past-year rates of ALA most often exceed past-year ALD. The
average past-year prevalence of AUDs for all countries combined was
2.2% and ranges from 0.1% in Iraq to 5.9% in the Ukraine.
Conditioning on past year alcohol use, the average past year pre-
valence for all countries combined was 2.6% for ALA, 1.8% for ALD,
and 4.4% for AUD. Iraq had the highest past year prevalence rate (joint
with New Zealand) of any survey for AUDs among past-year users
(7.3%) which sharply contrasts with its unconditional past-year AUD
estimate in which it reported the lowest of any survey (0.1%). The
lowest conditional past year prevalence of AUDs was from Japan
(1.1%).
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across WHO regions. The Eastern Mediterranean region had the lowest
prevalence estimates among WHO regions for alcohol use (28.9%), ALA
(0.5%), ALD (0.1%), and AUD (0.6%) and this pattern was consistent
when conditioning upon past-year use ALA (1.8%), ALD (0.4%), and
AUD (2.2%). The highest unconditional past year prevalence estimates
of alcohol use were from the Western European Region (65.6%), the
highest prevalence of ALA was from the Eastern Europe region (1.9%)
the highest prevalence of ALD was from the Western Pacific and Region
of the Americas (1.2%), and the highest prevalence of AUD was from
the Eastern Europe region (3.0%). When excluding alcohol abstainers,
the Western Pacific surveys had the highest prevalence estimates for
past year ALA (3.3%), ALD (2.5%) and AUD (5.8%).
There were significant differences between income groups for ALA
and AUDs but not ALD when alcohol abstainers were excluded, though
there were no significant differences when they were included.
Unconditional AUD prevalence ranged from 2.0% in low/lower-middle
income surveys to 2.3% in upper-middle income surveys while condi-
tional AUD prevalences ranged from 3.4% in lower income surveys to
4.8% in high income surveys.
4.3. Remission
Remission among people with lifetime AUD was defined at time of
interview as having had more than 12months, or at least two birthdays,
since the last disorder related problem. Table 4 shows prevalence of
remission at the time of interview among lifetime ALA, ALD and all
AUD cases as well as among AUD cases that had at least one non-sub-
stance use mental disorders (MHD). For all conditional groups, there
were significant differences in the prevalence of AUD remission across
countries, income levels and regions. The average prevalence of ALA
remission for all countries was 79.5% and 59.7% for ALD. The average
prevalence of AUD remission was 75.2%, ranging from 58.2% in Uk-
raine to 89.3% in Japan. When conditioning on specific disorders, the
average remission prevalence was higher among ALA (79.5%) com-
pared to ALD (59.7%) cases, with this same trend consistent within
most survey-specific comparisons. Among those with at least one MHD,
the average prevalence of AUD remission was 72.5%, ranging from
47.9% in Lebanon to 94.5% in Spain.
4.4. Gender
Table 5 shows 12-month and lifetime prevalences for AUD by
gender. The average past year prevalence of AUD for all countries was
0.9% for women, ranging from no past year cases in Iraq and Nigeria to
2.6% in Australia. The average past year prevalence for all countries
was 3.6% for men ranging from 0.2% in Iraq to 11.6% in the Ukraine.
Among women, the average lifetime prevalence of AUD for all countries
was 3.4% ranging from no lifetime cases in Iraq to 12.1% in Australia.
The average lifetime prevalence of AUDs for men was 14.1% for all
countries and ranges from 1.4% in Iraq to 33.4% in Australia. In all
surveys, the prevalence estimates of both lifetime and 12-month AUDs
were higher for men than women.
4.5. Disorder persistence
Using the retrospective data on determinations of past AUD it is
possible to compute an indirect indicator of disorder persistence as the
proportion of lifetimes cases of ALA, ALD and AUDs among subjects
who also met criteria for the same diagnosis in the 12months before
interview (Table 6). Significant differences can be seen across countries,
survey income groups and WHO regions. Overall, a quarter of re-
spondents who had ever had an AUD continued to have at least some
symptoms of the disorder in the past year. For all countries combined,
the rates of past-year persistence were 21.4% for ALA, 36.7% for ALD
and 25.5% for AUD. There was significant variation for all diagnoses
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43.3% in the Ukraine. Significant variation was also observed between
income groups, with persistence highest for ALA among upper-middle
income countries at 29.6% and for ALD and AUD among low/lower-
middle income countries at 53.8% and 34.1%, respectively. Although
Tables 2 and 3 show ALA as being a more prevalent disorder than ALD,
the estimates presented in Table 6 show ALD to be a more persistent
disorder.
4.6. Age of onset
Figure 1 displays AUD AOO curves among those with a lifetime AUD
by survey income group. The earliest 15% of lifetime AUD cases across
all survey income groups combined had onset before 18 years of age,
which means that of those individuals who will develop an AUD at
some time in their life, 15% will do so before age 18. For higher
Table 4
Prevalence of remission from alcohol use disorders among those with specific disorders.a




Remission among all DSM-IV
use disorder casese
Remission from an AUD among those with
DSM-IV alcohol use disorder and at least one
other mental disorderb,e
% SE % SE % SE % SE
Low-Lower middle income
countries
74.4 1.5 46.2 2.7 67.3 1.4 62.2 3.2
Colombia 84.0 2.8 49.5 5.6 74.7 3.0 68.6 4.7
Iraq 78.4 11.9 93.9 5.2 82.8 9.8 60.0 27.1
Nigeria 76.1 2.8 32.6 10.7 69.7 2.8 63.2 8.4
Peru 76.6 3.9 62.5 6.2 73.0 2.6 73.1 6.2
PRC China 78.5 3.3 39.9 8.3 69.9 3.7 52.7 11.3
Ukraine 65.0 2.7 40.0 4.1 58.2 2.3 50.0 6.9
Upper-middle income countries 71.5 1.7 59.1 2.9 67.0 1.5 65.5 2.5
Brazil 74.0 3.1 61.3 3.8 69.8 2.5 66.1 3.7
Bulgaria 67.3 5.6 68.1 7.3 67.5 4.0 75.1 7.9
Colombia (Medellin) 83.4 3.8 65.3 7.3 76.6 3.6 78.0 4.2
Lebanon 74.6 9.7 29.0 10.9 63.3 9.5 47.9 10.3
Mexico 76.9 4.3 – – – – – –
Romania 82.3 7.0 38.6 11.5 72.6 7.4 56.2 17.5
South Africa 61.1 3.4 54.0 6.7 59.4 3.0 58.4 4.9
High income countries 82.9 0.7 67.2 2.0 80.8 0.8 77.6 1.5
Argentina 82.4 2.5 79.0 7.7 81.9 2.4 84.5 4.1
Australia 86.4 1.2 64.3 3.5 82.5 1.3 76.8 2.7
Belgium 79.9 4.3 82.9 3.8 80.5 3.6 78.9 6.7
France 87.3 2.7 66.2 8.7 82.7 3.5 88.6 3.9
Germany 85.3 2.8 78.8 6.7 83.8 3.0 85.3 7.1
Israel 74.1 3.2 68.4 10.7 73.5 3.0 67.1 6.7
Italy 91.3 5.0 73.8 9.0 86.4 4.5 79.3 12.8
Japan 92.4 2.8 66.3 9.2 89.3 2.9 91.1 3.9
New Zealand 80.5 1.7 – – – – – –
Northern Ireland 79.8 3.4 69.8 7.2 77.9 3.1 78.0 3.7
Poland 77.0 2.8 44.4 5.8 70.5 2.3 63.5 4.1
Portugal 85.4 3.2 80.5 7.9 84.7 3.0 81.1 3.8
Spain 81.4 4.0 82.5 9.9 81.6 3.9 94.5 4.0
Spain (Murcia) 86.8 6.9 79.4 13.5 85.2 5.7 75.2 7.6
The Netherlands 81.4 3.8 71.8 8.1 79.8 3.3 74.6 8.3
The United States 80.3 1.6 – – – – – –
All countries combined 79.5 0.6 59.7 1.5 75.2 0.6 72.5 1.2
WHO regionsc
Region of the Americas 79.4 1.2 60.1 2.7 74.0 1.4 72.8 2
African Region 65.0 2.6 50.6 6.0 61.8 2.4 58.8 4.5
Western Pacific Region 84.1 0.9 61.1 3.2 81.5 1.2 76.8 2.6
Eastern Mediterranean Region 74.6 3.0 63.2 9.1 72.9 2.9 63.5 6.5
Western European Region 83.3 1.3 75.7 2.8 81.8 1.2 80.8 1.9
Eastern European Region 70.5 1.8 45.3 3.1 64.3 1.5 58.2 3.7
Comparison between countriesd F(28,5333)= 4.3 F(25,5070)= 3.7 F(25,5070)= 6.9 F(28,5070)= 3.3
P < .0001 P < .0001 P < .0001 P < .0001
Comparison between low, middle
and high income country
groupsd
F(2,5359)= 26.4 F(2,5093)= 17.6 F(2,5093)= 53.4 F(2,5093)= 14.4
P < .0001 P < .0001 P < .0001 P < .0001
Comparison between WHO
regionsd
F(5,5356)= 15.7 F(5,5090)= 10.5 F(5,5090)= 26.2 F(5,5090)= 8.7
P < .0001 P < .0001 P < .0001 P < .0001
a Remission is defined as having reported more than 12months, or at least two birthdays, since the last disorder related problem.
b Includes lifetime presence of any of the following: major depressive disorder, dysthymic disorder, bipolar disorder, panic disorder, generalized anxiety disorder,
agoraphobia, social phobia, specific phobia, childhood or adult separation anxiety, posttraumatic stress disorder, attention deficit/hyperactivity disorder, conduct
disorder, intermittent explosive disorder, and oppositional defiant disorder.
c Region of the Americas (Argentina, Brazil, Colombia, Medellin, Mexico, Peru, the United States); African region (Nigeria, South Africa); Western Pacific region
(Australia, Japan, New Zealand, PRC China (Beijing and Shanghai)); Eastern Mediterranean region (Iraq, Israel, Lebanon); Western European region (Belgium,
France, Germany, Italy, The Netherlands, Northern Ireland, Portugal, Spain, Spain(Murcia)); Eastern European region (Bulgaria, Poland, Romania, Ukraine).
d Wald design-corrected F-tests were used to determine if there is variation in prevalence estimates across countries.
e Remission from dependence could not be assessed in the United States, New Zealand and Mexico (see eMethods).
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percentages of AUDs, AOO generally decreased as survey income level
increased. The median AOO for AUDs was 21 years in high-income
survey countries, 23 years in upper-middle income countries and
24 years in low/lower-middle income countries.
4.7. Demographics
Consistent with previous studies, men were significantly more likely
than women to have a lifetime or past year persistent AUD (Table 7).
The odds for men having a lifetime AUD were 4.6 (95% CI 4.3–4.9)
times the odds for women and, among those with a lifetime AUD, the
odds for a past year AUD among men were 1.2 (95% CI 1.0–1.4) times
the odds for women.
Based on age at interview, younger cohorts were more likely to have
a lifetime AUD and past year AUD persistence, with respondents aged
18–29 years having the highest odds for both lifetime (OR 10.4, 95% CI
9.2–11.7) and persistent past-year (OR 3.1, 95% CI 2.2–4.3) AUD
compared to those aged 60 or over at time of interview. Employment
status was significantly associated with development and persistence of
AUD, with students less likely to develop a lifetime AUD (OR 0.8, 95%
CI 0.7–1.0) but significantly more likely to persist once developing the
disorder (OR 1.5, 95% CI 1.1–2.1) compared to those in employment.
Marital status was significantly associated with lifetime and past year
persistence of AUD, with divorced, separated or widowed respondents
associated with the greatest odds of lifetime AUD (OR 1.6, 95% CI
1.5–1.7) and the never-married at elevated odds of both lifetime (OR
1.3, 95% CI 1.2–1.4) and persistent past-year AUD (OR 1.9, 95% CI
1.7–2.2) compared to those married at time of interview. Education
level was significantly associated with lifetime AUD and past year AUD
among lifetime cases, with a general trend of an inverse association
between educational attainment and likelihood of an AUD. Household
income was a significant predictor of lifetime AUD, with those from low
(OR 1.2, 95% CI 1.2–1.3) and low-average (OR 1.1, 95% CI 1.1–1.2)
income households significantly more likely to develop the disorder
compared to persons living in high income households.
4.8. Onset relative to other mental disorders
AUDs are highly comorbid with MHD (Table 8). Among respondents
with a lifetime AUD, 43.9% had at least one other lifetime MHD, and
among those who had ever experienced any MHD, 17.9% had a lifetime
AUD. Of those with a past year AUD, 58.6% had at least one other
lifetime MHD and 42.9% had at least one other MHD in the same 12-
month period (Appendix Table 1). Regarding the ordering of onset of
these disorders, the MHD most often preceded the onset of the AUD, as
was the case for dysthymia, agoraphobia, social phobia, specific pho-
bias, separation anxiety, ADHD, conduct disorder, intermittent ex-
plosive disorder (IED) and oppositional defiant disorder (ODD). The
exceptions were bipolar disorder, panic disorder, and generalized an-
xiety disorder (GAD) where no significant trend in temporal order of
onset was observed, and major depressive disorder (MDD), where AUD
onset most often occurred prior to disorder onset.
5. Discussion
The mean lifetime prevalence of AUDs in the 29 WMH surveys
combined was 8.6%, ranging from 0.7% in Iraq to 22.7% in Australia.
The combined mean 12-month AUD prevalence was 2.2%, ranging from
0.1% in Iraq to 5.9% in the Ukraine. This is a high level of disorder
prevalence given the substantial health and economic burdens asso-
ciated with AUDs (Moskalewicz, Room, & Thom, 2016; Peacock, Leung,
Larney, et al., 2018; Webb, Bromet, Gluzman, et al., 2005). Although
the AUD prevalence estimates range widely across the WMH countries,
these estimates and the variations are consistent with findings from
other national and regional surveys (Mathers & Ayuso-Mateos, 2003;
Adlaf, Begin, & Sawka, 2005; Bromet, Gluzman, Paniotto, et al., 2005;
Chen & Yin, 2008; Cochrane, Chen, Conigrave, et al., 2003; Hasin,
Stinson, Ogburn, et al., 2007; Lukassen & Beaudet, 2005; Rehm, Room,
Van Den Brink, et al., 2005; Taylor, 2007; Ulaş, Binbay, Kırlı, et al.,
2017; Wittchen & Jacobi, 2005). There was also a relatively wide cross-
national range of AUD prevalence estimates among lifetime non-ab-
stainers. The combined lifetime prevalence of AUDs among non-ab-
stainers was 10.7%, ranging from 1.7% in Italy to 28.3% in South Africa
and the combined 12-month prevalence of AUDs among non-abstainers
Table 5























% SE % SE % SE
Low-Lower middle
income countries
1.1 0.1 10.9 0.4 0.4 0.1 3.7 0.2
Colombia 2.3 0.4 18.0 1.3 0.5 0.2 5.1 0.7
Iraq – – 1.4 0.5 – – 0.2 0.2
Nigeria 0.1 0.1 4.5 0.4 – – 1.4 0.2
Peru 0.9 0.2 10.9 0.7 0.3 0.1 2.9 0.3
PRC China 0.5 0.2 8.5 0.8 0.2 0.1 2.6 0.5
Ukraine 2.9 0.4 26.9 1.5 1.3 0.2 11.6 1.0
Upper-middle income
countries
2.3 0.2 12.5 0.4 0.8 0.1 4.0 0.3
Brazil 4.0 0.5 16.4 1.1 1.2 0.3 5.3 0.6
Bulgaria 0.6 0.2 5.9 0.6 0.3 0.1 2.0 0.3
Colombia (Medellin) 5.3 0.7 21.4 2.8 1.4 0.4 5.3 1.0
Lebanon 0.4 0.3 2.8 0.6 0.4 0.3 0.8 0.3
Mexico 1.3 0.3 15.4 1.1 0.2 0.2 4.3 0.7
Romania 0.2 0.1 6.4 0.6 0.1 0.1 1.6 0.5
South Africa 5.0 0.6 19.0 1.4 2.0 0.3 8.0 0.9
High income countries 4.8 0.1 16.3 0.3 1.1 0.1 3.4 0.1
Argentina 3.0 0.5 14.1 1.4 0.7 0.2 2.6 0.4
Australia 12.1 0.7 33.4 1.1 2.6 0.3 5.6 0.5
Belgium 2.1 0.6 14.6 1.6 0.5 0.2 2.9 0.7
France 2.0 0.3 12.7 1.0 0.2 0.1 2.4 0.5
Germany 1.7 0.3 11.6 1.1 0.4 0.1 1.9 0.4
Israel 1.1 0.2 7.8 0.6 0.3 0.1 2.0 0.3
Italy 0.2 0.1 2.4 0.4 0.1 0.1 0.3 0.1
Japan 2.5 0.7 12.9 1.3 0.2 0.1 1.3 0.4
New Zealand 7.2 0.4 17.4 0.6 1.8 0.2 4.3 0.3
Northern Ireland 5.8 0.6 21.2 1.8 1.5 0.3 4.7 0.9
Poland 3.4 0.4 18.9 0.9 0.6 0.1 6.4 0.5
Portugal 2.3 0.4 18.4 1.9 0.4 0.2 2.8 0.6
Spain 1.0 0.2 6.5 0.8 0.1 0.0 1.4 0.3
Spain (Murcia) 1.2 0.4 11.4 1.3 0.1 0.0 1.8 0.7
The Netherlands 3.7 0.6 14.3 1.6 1.0 0.3 2.8 0.6
The United States 7.8 0.5 20.5 1.0 1.9 0.3 4.8 0.4




3.5 0.2 16.6 0.5 0.9 0.1 4.4 0.2
African Region 2.1 0.3 10.0 0.6 0.8 0.1 3.9 0.3
Western Pacific
Region
7.3 0.3 20.2 0.5 1.7 0.1 4.2 0.2
Eastern Mediterranean
Region
0.6 0.1 4.3 0.3 0.2 0.1 1.1 0.2
Western European
Region
1.9 0.1 10.8 0.4 0.4 0.1 2.0 0.2
Eastern European
Region
1.9 0.2 15.0 0.5 0.6 0.1 5.7 0.3
A dash indicates a zero cell count.
a Region of the Americas (Argentina, Brazil, Colombia, Medellin, Mexico,
Peru, the United States); African region (Nigeria, South Africa); Western Pacific
region (Australia, Japan, New Zealand, PRC China (Beijing and Shanghai));
Eastern Mediterranean region (Iraq, Israel, Lebanon); Western European region
(Belgium, France, Germany, Italy, The Netherlands, Northern Ireland, Portugal,
Spain, Spain(Murcia)); Eastern European region (Bulgaria, Poland, Romania,
Ukraine).
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was 4.4% ranging from 1.1% in Japan to 7.3% in Iraq and New Zealand.
Both AUD remission and persistence were common. The average pre-
valence of remission for at least the last year was 79.5% for ALA, 59.7%
for ALD, and 75.2% for AUD while the average prevalence of past-year
persistence was 21.4% for ALA, 36.7% for ALD and 25.5% for AUD.
The rank ordering across countries of lifetime prevalence estimates
in the total population and non-abstainers was the same or similar for
most countries but notably dissimilar in a few countries. For example,
among all WMH surveys, Iraq had the lowest population prevalence of
both past year and lifetime AUDs but for the subgroup of non-lifetime
abstainers, Iraq had the highest 12-month prevalence and the third
highest prevalence of lifetime AUDs. Iraq's general population had a
relatively low risk for AUDs which may suggest that AUDs are not a
significant concern in Iraq. However, among those who had ever used
alcohol, the risk for AUDs was comparatively high (19.2%). A large
difference was also found in South Africa comparing the AUD
prevalence in the general population (11.5%) and among users
(28.3%).
There were significant differences in AUD prevalence across the
WHO Regions. The Eastern Mediterranean region which had the lowest
per capita alcohol consumption and the lowest proportion of drinkers
also had the lowest past year and lifetime AUD prevalences. Presumably
low consumption and high abstention are limiting factors on the de-
velopment of AUDs in the general population of a country or region.
Supporting this, the range of AUD prevalences across the WHO Regions
narrows when considering only lifetime alcohol non-abstainers.
However, the limiting effect of low consumption and high abstention
may exert more influence at lower levels of alcohol consumption. While
the annual per capita alcohol consumption of both France and Australia
is relatively high at 12.2 litersl of pure alcohol (World Health
Organization, Management of Substance Abuse Unit, 2014), the life-
time prevalence of AUDs was 7.1% for France and 22.7% for Australia.
Table 6
Prevalence of past-year alcohol use disorders among those with lifetime alcohol use disorders in the World Mental Health Surveys.
Country N Past-year DSM-IV abuse among
lifetime DSM-IV alcohol abuse cases
Past-year DSM-IV dependence among
lifetime DSM-IV alcohol dependence cases
Past-year DSM-IV use disorder among
lifetime DSM-IV alcohol use disorder cases
% SE % SE % SE
Low-Lower middle income countries 29,366 27.5 1.6 53.8 2.8 34.1 1.4
Colombia 4426 19.1 3.2 50.6 6.3 27.6 3.2
Iraq 4332 21.6 11.9 6.1 5.2 17.2 9.8
Nigeria 6752 24.8 2.9 67.4 10.7 31.0 2.9
Peru 3930 24.2 3.5 37.5 6.2 27.6 2.3
PRC China 5201 22.8 3.4 60.1 8.3 31.1 3.7
Ukraine 4725 37.1 2.8 60.0 4.1 43.3 2.3
Upper-middle income countries 27,339 29.6 1.8 38.3 2.7 32.5 1.5
Brazil 5037 27.1 3.2 41.2 3.4 31.8 2.5
Bulgaria 5318 35.4 5.4 31.9 7.3 34.3 4.0
Colombia (Medellin) 1673 18.7 4.2 36.5 7.5 25.4 3.8
Lebanon 2857 25.4 9.7 71.0 10.9 36.7 9.5
Mexico 5782 23.6 4.4 31.5 5.7 27.3 3.9
Romania 2357 17.6 6.6 50.3 13.1 24.8 7.3
South Africa 4315 39.9 3.3 45.8 6.6 41.3 3.0
High income countries 66,532 17.8 0.7 31.8 1.3 21.4 0.7
Argentina 2116 18.1 2.6 26.6 7.5 19.3 2.5
Australia 8463 14.1 1.2 36.2 3.5 18.0 1.4
Belgium 2419 20.7 4.2 19.2 4.0 20.4 3.6
France 2894 13.4 3.0 33.8 8.7 17.9 3.6
Germany 3555 15.4 3.1 21.2 6.7 16.8 3.2
Israel 4859 25.9 3.2 31.6 10.7 26.5 3.0
Italy 4712 8.7 5.0 26.2 9.0 13.6 4.5
Japan 1682 7.6 2.8 27.8 8.6 10.0 2.7
New Zealand 12,790 19.7 1.8 32.3 2.1 24.6 1.5
Northern Ireland 1986 21.7 3.8 29.6 7.1 23.2 3.5
Poland 4000 25.0 2.8 56.0 5.8 31.3 2.3
Portugal 2060 15.1 3.3 19.5 7.9 15.7 3.1
Spain 5473 19.5 4.0 17.5 9.9 19.2 3.9
Spain (Murcia) 1459 13.2 6.9 20.6 13.5 14.8 5.7
The Netherlands 2372 20.0 3.9 28.2 8.1 21.3 3.4
The United States 5692 20.9 1.6 27.7 2.5 23.9 1.6
All countries combined 123,237 21.4 0.6 36.7 1.1 25.5 0.6
WHO regionsa
Region of the Americas 28,656 22.0 1.2 34.6 1.9 26.6 1.1
African Region 11,067 36.0 2.6 49.2 5.9 38.9 2.4
Western Pacific Region 28,136 16.3 1.0 35.1 1.8 21.2 0.9
Eastern Mediterranean Region 12,048 25.4 3.0 36.8 9.1 27.1 2.9
Western European Region 26,930 17.5 1.3 24.5 2.8 18.9 1.3
Eastern European Region 16,400 31.5 1.9 54.2 3.1 37.1 1.6
Comparison between countriesb F(28,5333)= 4.5 F(28,5333)= 3.8 P < .0001 F(28,5333)= 6.5 P < .0001
P < .0001
Comparison between low, middle and
high income country groupsb
F(2,5359)= 29.7 F(2,5359)= 21.8 P < .0001 F(2,5359)= 46.2 P < .0001
P < .0001
Comparison between WHO regionsb F(5,5356) =17.2 F(5,5356)= 11.0 P < .0001 F(5,5356)= 25.0 P < .0001
P < .0001
a Region of the Americas (Argentina, Brazil, Colombia, Medellin, Mexico, Peru, the United States); African region (Nigeria, South Africa); Western Pacific region
(Australia, Japan, New Zealand, PRC China (Beijing and Shanghai)); Eastern Mediterranean region (Iraq, Israel, Lebanon); Western European region (Belgium,
France, Germany, Italy, The Netherlands, Northern Ireland, Portugal, Spain, Spain(Murcia)); Eastern European region (Bulgaria, Poland, Romania, Ukraine).
b Wald design-corrected F-tests were used to determine if there is variation in prevalence estimates across countries.
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There are probably a number of contributors to this difference, but one
possible factor might be a difference in the prevalence of heavy episodic
or binge drinking which has been found to have relatively more severe
consequences and association with AUDs than temperate patterns
(Rehm, Rehn, Room, et al., 2003). Studies have found that France has
the lowest level of binge drinking in Europe(Leifman, 2002) while
Australia has comparatively high rates (Toumbourou, Beyers, Catalano,
et al., 2005; Yang, Zhao, & Srivastava, 2016). Some view heavy episodic
drinking as a primary indicator of severe alcohol use problems and have
recommended that AUDs, particularly dependence, be measured via
heavy drinking over time with diagnosis thresholds set in average per
day consumption of alcohol(Rehm, 2016; Rehm & Room, 2017; Wood,
Kaptoge, Butterworth, et al., 2018). The WMH findings suggest that
alcohol consumption measures may enhance understanding of psy-
chiatric epidemiological findings.
Other potentially limiting contextual factors may account for and
possibly reflect some of the cross-national variation in prevalence of
AUDs. Some of these may include social-cultural influences(Gordon,
Heim, & Macaskill, 2012; Savic, Room, Mugavin, et al., 2016) such as
parental involvement, drinking culture, and stigma while other factors
may be more policy related(Babor, Caetano, Casswell, et al., 2010;
Simpura, Karlsson, & Leppänen, 2002) such as legal sanctions, en-
forcement of prohibitions and alcohol availability, all of which may be
subject to change over time. The possible influence of these factors is
important to interpretation of the country AUD prevalences and to in-
ferences about explanations for the varying AUD prevalences. However,
interpretations should not assume simple causality and speculations
must be cautious regarding how prevalences might change if different
Figure 1. Age of DSM-IV alcohol use disorder onset distributions among those
with a diagnosis by survey income groups.
Table 7
Bivariate associations between sociodemographic correlates and DSM-IV alcohol use disorder.
Prevalence of AUD according to… Lifetime DSM-IV alcohol use disordera Past-year DSM-IV alcohol use disorder among lifetime alcohol use disorderb
% (SE) OR (95% CI) % (SE) OR (95% CI)
Gender
Male 14.1 (0.2) 4.6⁎ (4.3–4.9) 25.6 (0.6) 1.2⁎ (1.0–1.3)
Female 3.4 (0.1) 1 25.3 (1.1) 1
F-value [p] 2608.0⁎ [< 0.001] 5.7⁎ [0.017]
Age-cohort
18–29 9.1 (0.2) 10.4⁎ (9.2–11.7) 41.0 (1.2) 3.1⁎ (2.2–4.3)
30–44 9.8 (0.2) 6.0⁎ (5.5–6.6) 23.6 (0.9) 1.8⁎ (1.3–2.4)
45–59 9.4 (0.2) 3.4⁎ (3.1–3.8) 17.5 (0.9) 1.7⁎ (1.3–2.3)
60+ 4.6 (0.2) 1 7.8 (0.8) 1
F-value [p] 551.5⁎ [< 0.001] 22.0⁎ [< 0.001]
Employment status
Student 5.9 (0.5) 0.8⁎ (0.7–1.0) 40.4 (3.7) 1.5⁎ (1.1–2.1)
Homemaker 3.6 (0.2) 0.9⁎ (0.8–1.0) 22.4 (2.0) 1.0 (0.8–1.3)
Retired 4.7 (0.2) 0.8⁎ (0.7–0.9) 10.7 (1.2) 0.9 (0.7–1.1)
Other 11.6 (0.4) 1.5⁎ (1.4–1.6) 34.3 (1.6) 1.4⁎ (1.2–1.6)
Employed 10.2 (0.2) 1 24.9 (0.6) 1
F-value [p] 36.8⁎ [< 0.001] 5.4⁎ [< 0.001]
Marital status
Never married 10.6 (0.3) 1.3⁎ (1.2–1.4) 38.4 (1.1) 1.9⁎ (1.7–2.2)
Divorced/separated/widowed 9.2 (0.3) 1.6⁎ (1.5–1.7) 19.5 (1.2) 1.1 (0.9–1.3)
Currently married 7.6 (0.1) 1 19.7 (0.7) 1
F-value [p] 80.9⁎⁎ [< 0.001] 44.1⁎ [< 0.001]
Education level
No education 2.4 (0.3) 1.2 (0.9–1.6) 35.1 (6.3) 2.5⁎ (1.3–5.0)
Some primary 7.1 (0.4) 1.7⁎ (1.5–2.0) 22.0 (1.9) 1.3 (0.9–1.7)
Finished primary 6.4 (0.3) 1.7⁎ (1.5–1.9) 25.5 (2.1) 1.3 (1.0–1.8)
Some secondary 9.9 (0.2) 1.7⁎ (1.6–1.9) 27.2 (1.2) 1.3⁎ (1.1–1.6)
Finished secondary 8.9 (0.2) 1.4⁎ (1.2–1.5) 26.4 (1.0) 1.2 (1.0–1.4)
Some college 11.5 (0.3) 1.4⁎ (1.3–1.5) 26.5 (1.3) 1.3⁎ (1.1–1.6)
Finished college 7.7 (0.3) 1 22.5 (1.3) 1
F-value [p] 25.7⁎ [< 0.001] 2.2⁎ [0.042]
Household income
Low 9.9 (0.2) 1.2⁎ (1.2–1.3) 27.9 (1.1) 1.3⁎ (1.1–1.5)
Low-average 9.5 (0.2) 1.1⁎ (1.1–1.2) 25.5 (1.2) 1.1 (1.0–1.3)
High-average 9.2 (0.2) 1.0 (1.0–1.1) 25.1 (1.1) 1.1 (0.9–1.3)
High 10.2 (0.3) 1 23.8 (1.1) 1
F-value [p] 15.0⁎ [< 0.001] 2.5 [0.060]
⁎ Significant at the 0.05 level, 2-sided test.
a Estimates are based on discrete-time logistic regression analyses controlling for age-cohorts, gender, person-years and country.
b Estimates are based on logistic regression model adjusted for time since AUD onset, gender and country.
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environmental and social conditions were instituted.
There is evidence that in Europe, North America, and Australia
adolescent levels of drinking have declined in recent years, perhaps in
relation to changing socio-environmental factors(De Looze,
Raaijmakers, Ter Bogt, et al., 2015; Group, 2016; Kuntsche, Kuntsche,
Knibbe, et al., 2011; Livingston, 2014; Miech, Johnston, O'malley,
et al., 2017). However, alcohol consumption is stable or increasing in
other regions(World Health Organization, 2018) and there are reports
that abstaining or moderate alcohol using adolescents often con-
siderably increase consumption to heavy drinking as young adults
(Jager, Keyes, & Schulenberg, 2015; White, Castle, Chen, et al., 2015;
World Health Organization, 2018) and that middle-age and older adults
may be increasingly engaging in binge drinking(Grucza, Sher, Kerr,
et al., 2018).
Despite changes in alcohol use in different ages and regions, varying
sociocultural environments, and the range of AUD prevalences, the
multinational WMH results confirm a number of well-documented
clinical and epidemiological findings from more local studies. For ex-
ample, AUD prevalences are much higher for men than women(Obot &
Room, 2005). Risk for onset of AUD begins in adolescence with half of
all lifetime cases beginning by age 23 although new onsets continue
through later life(Ystrom, Kendler, & Reichborn-Kjennerud, 2014).
Being married(Leonard & Rothbard, 1999) and more educated(Barr,
Salvatore, Maes, et al., 2016) is associated with lower risk for AUD.
Comorbidity with other mental disorders is common(Lai, Cleary,
Sitharthan, et al., 2015) and mental health disorders often precede
AUDs(Swendsen, Conway, Degenhardt, et al., 2010). Despite the harms
and impairments associated with AUDs, there is a low prevalence of
treatment(Grant, Goldstein, Saha, et al., 2015). The consistency of the
patterns of AUDs and correlates across the surveyed countries provides
an informative perspective on the relatively consistent nature of AUDs.
AUD prevalences were much higher for men than women with the odds
for men having a lifetime AUD being 4.6 times the odds for women.
Risk for onset of AUD began in adolescence with 15% of all lifetime
cases developing before age 18 although new onsets continued through
later life. Being older at time of interview, being married, being more
educated, and having a higher household income were all associated
with a lower risk for AUD and for AUD persistence.
The WMH findings also corroborate and extend previous research
on AUD – MHD comorbidities (Grant et al., 2015; Grant, Stinson,
Dawson, et al., 2004; Jan-Llopis & Matytsina, 2006; Lai et al., 2015;
Merikangas, Mehta, Molnar, et al., 1998). Comorbidity with MHDs is
common with 43.9% of individuals with a lifetime AUD having had at
least one lifetime MHD. Among respondents with a lifetime MHD,
17.9% had a lifetime AUD. For most of the MHD categories considered
(dysthymia, all phobias, separation anxiety, ADHD, conduct disorder,
IED, and ODD) when there were MHD – AUD comorbidities, the onset
of the MHD most often preceded the onset of the AUD. No significant
trends in order of onset were observed for bipolar disorder, panic dis-
order, and GAD. The onset of AUD most often preceded the onset of
only one disorder, MDD.
Onsets of MHD and AUD disorders are often not discrete events
occurring at a single point in time and developing symptoms of co-
morbid disorders may reciprocally influence each other(Glantz, 1992;
Glantz & Leshner, 2000). This complicates assessment of the exact
temporal order of the onset of emerging disorders. In addition, research
suggests that AUDs and mood, anxiety and other impulse-control re-
lated mental disorders may share common underlying influences or
pathways (Hasin et al., 2007; Kessler, Ormel, Petukhova, et al., 2011).
There is growing interest in characterizations of mental illness that rely
on dimensional rather than categorical frameworks(Caspi, Houts,
Belsky, et al., 2014; Conway, Forbes, Forbush, et al., 2019; Kotov,
Krueger, Watson, et al., 2017). Proposals such as these, most notably
the Hierarchical Taxonomy of Psychopathology - HiTOP, are in the
early stages of formulation and empirical validation but might facilitate
understanding of comorbidities, underlying influences, and common
transdiagnostic factors. The cross-national findings of prevalent co-
morbidities in the WMH surveys lend support for further explorations of
dimensional approaches. In addition, the WMH findings corroborate
local findings and affirm the potential value of further understanding of
MHD – SUD comorbidities which is planned for future WMH research.
Limitations of the WMH surveys must be considered. As data come
from 27 countries there is not a full representation of all regions, in-
come levels and other country characteristics. Response rates and the
year in which the surveys were administered varied across surveys, and
cross-national differences in willingness to disclose personal informa-
tion about alcohol use and associated problems are possible. The re-
spondent information is subject to the limitations of retrospective re-
porting. The WMH surveys rely solely on household surveys. Data from
subgroups that may differ from the larger national populations in terms
of AUD prevalences and correlates were not included such as the
homeless, people in jails, prisons, hospitals, halfway houses, SUD in-
patient treatment facilities, or living on military bases. Although the
WMH sampling does not include individuals who were residing in in-
patient treatment facilities at the time of the interview, the sampling
does not exclude individuals who were either in outpatient treatment at
the time of the interview or who received either outpatient or inpatient
treatment at any time prior to the interview. Nevertheless, if the WMH
had specifically included current clinical AUD samples it is likely that
more severe cases would have been identified(Rehm, Allamani, Aubin,
et al., 2015).
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